CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 51  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0728
LYS 10.0728
GLU 20.0315
LEU 30.0297
ARG 40.0297
CYS 50.0219
GLN 60.0241
CYS 70.0168
ILE 80.0156
LYS 90.0271
THR 100.0055
TYR 110.0051
SER 120.0141
LYS 130.0258
PRO 140.0212
PHE 150.0159
HIS 160.0447
PRO 170.0099
LYS 180.0072
PHE 190.0052
ILE 200.0024
LYS 210.0083
GLU 220.0064
LEU 230.0028
ARG 240.0090
VAL 250.0062
ILE 260.0130
GLU 270.0160
SER 280.0148
GLY 290.0048
PRO 300.0166
HIS 310.0187
CYS 320.0070
ALA 330.0301
ASN 340.0315
THR 350.0272
GLU 360.0135
ILE 370.0060
ILE 380.0028
VAL 390.0042
LYS 400.0072
LEU 410.0046
SER 420.0080
ASP 430.0177
GLY 440.0017
ARG 450.0080
GLU 460.0084
LEU 470.0071
CYS 480.0060
LEU 490.0028
ASP 500.0086
PRO 510.0146
LYS 520.0649
GLU 530.0234
ASN 540.0192
TRP 550.0083
VAL 560.0046
GLN 570.0091
ARG 580.0154
VAL 590.0042
VAL 600.0058
GLU 610.0142
LYS 620.0179
PHE 630.0082
LEU 640.0113
LYS 650.0122
ARG 660.0221
ALA 670.0433
GLU 680.0467
ASN 690.0324

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.